KRIT1 Haploinsufficiency Alters Hepatic Lipid/Sphingolipid Metabolism: Exacerbation by a High Fructose Diet

Abstract Background. Loss-of-function mutations in KRIT1 gene cause familial cerebral cavernous malformations (CCM), a neurovascular disorder characterized by fragile, leaky capillaries in brain. Beyond its role in vascular integrity, KRIT1 also regulates redox and metabolic signaling, yet its systemic impact remains poorly understood. Given its involvement in mevalonate pathway signaling and modulation of the RhoA/ROCK/YAP axis, we investigated whether KRIT1 haploinsufficiency alters hepatic lipid and sphingolipid metabolism and how dietary stress may exacerbate these effects. Methods. Wild-type (WT) and KRIT1 heterozygous (HZ) mice were fed either a control or high-fructose (60%) diet for 22 weeks. Hepatic glycative stress, S1P pathway components, inflammatory and fibrotic markers, and RhoA/ROCK/YAP signaling were assessed via molecular, histological, and biochemical analyses. In vitro, KRIT1-silenced and KRIT1-overexpressing fibroblasts were used to validate KRIT1-dependent regulation of lipid and S1P metabolism. Results. KRIT1 haploinsufficiency induced hepatic steatosis, increased de novo lipogenesis, S1P synthesis and S1PR1/S1PR3 expression, alongside AGE/RAGE axis, inflammatory and fibrotic markers. A high-fructose diet amplified these changes, enhancing activation of the S1P/RhoA/ROCK/YAP axis and liver pathology. In vitro studies confirmed direct involvement of KRIT1 in lipid homeostasis and pro-inflammatory signaling. Conclusion. Our findings reveal a novel systemic function of KRIT1 in maintaining hepatic lipid and sphingolipid balance through the S1P/RhoA/ROCK/YAP pathway. Dietary fructose exacerbates KRIT1-dependent metabolic dysregulation, providing new insights into gene–environment interactions that may contribute to CCM progression and extracerebral comorbidities. These results broaden the pathological framework of KRIT1 beyond the cerebral endothelium and highlight the metabolic context as a key modifier of disease expression.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11455639/v1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

KRIT1 Haploinsufficiency Alters Hepatic Lipid/Sphingolipid Metabolism: Exacerbation by a High Fructose Diet

Federica Dal Bello, Raffaella Mastrocola, Claudia Fornelli, Andrea Perrelli et al.
1 links
Research Square
Liver Disease Diagnosis and Treatment
preprint

KRIT1 Haploinsufficiency Alters Hepatic Lipid/Sphingolipid Metabolism: Exacerbation by a High Fructose Diet

Federica Dal Bello, Raffaella Mastrocola, Claudia Fornelli, Andrea Perrelli, Saverio Francesco Retta, Chiara Ferraris, Luca Goitre, Giada Corsini
preprint en

Abstract

Abstract Background. Loss-of-function mutations in KRIT1 gene cause familial cerebral cavernous malformations (CCM), a neurovascular disorder characterized by fragile, leaky capillaries in brain. Beyond its role in vascular integrity, KRIT1 also regulates redox and metabolic signaling, yet its systemic impact remains poorly understood. Given its involvement in mevalonate pathway signaling and modulation of the RhoA/ROCK/YAP axis, we investigated whether KRIT1 haploinsufficiency alters hepatic lipid and sphingolipid metabolism and how dietary stress may exacerbate these effects. Methods. Wild-type (WT) and KRIT1 heterozygous (HZ) mice were fed either a control or high-fructose (60%) diet for 22 weeks. Hepatic glycative stress, S1P pathway components, inflammatory and fibrotic markers, and RhoA/ROCK/YAP signaling were assessed via molecular, histological, and biochemical analyses. In vitro, KRIT1-silenced and KRIT1-overexpressing fibroblasts were used to validate KRIT1-dependent regulation of lipid and S1P metabolism. Results. KRIT1 haploinsufficiency induced hepatic steatosis, increased de novo lipogenesis, S1P synthesis and S1PR1/S1PR3 expression, alongside AGE/RAGE axis, inflammatory and fibrotic markers. A high-fructose diet amplified these changes, enhancing activation of the S1P/RhoA/ROCK/YAP axis and liver pathology. In vitro studies confirmed direct involvement of KRIT1 in lipid homeostasis and pro-inflammatory signaling. Conclusion. Our findings reveal a novel systemic function of KRIT1 in maintaining hepatic lipid and sphingolipid balance through the S1P/RhoA/ROCK/YAP pathway. Dietary fructose exacerbates KRIT1-dependent metabolic dysregulation, providing new insights into gene–environment interactions that may contribute to CCM progression and extracerebral comorbidities. These results broaden the pathological framework of KRIT1 beyond the cerebral endothelium and highlight the metabolic context as a key modifier of disease expression.

Research Square
University of Rochester Medical Center (US), University of Rochester (US), University of Turin (IT)
Fondazione CRT, Università degli Studi di Torino
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon